monoclonal antibody— 单克隆抗体 monoclonal形— 巨球形 查看其他译文 © Linguee 词典, 2024 使用DeepL翻译器,即刻翻译文本和文档 随打随译 世界领先的质量 拖放文件 立刻翻译 ▾ 外部资源(未审查的) Its most advanced program is MOR103, a first-in-class,fully human antibodyagainst GM-CSF. ...
Disclosed is a fully human monoclonal antibody against complement C3 molecules. In a CHO cell lysis inhibition experiment, the antibody has a significant effect on inhibiting the lysis of antibody-sensitized CHO cells and red blood cells, and can significantly improve the survival rate of mice in ...
求翻译:a fully human monoclonal antibody是什么意思?待解决 悬赏分:1 - 离问题结束还有 a fully human monoclonal antibody问题补充:匿名 2013-05-23 12:21:38 一个完全的人类单克隆抗体 匿名 2013-05-23 12:23:18 一个充分地人的单克抗体 匿名 2013-05-23 12:24:58 正在翻译,请等待... 匿名 201...
A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments . Nat Biotechnol 1999 ; 17 : 276 - 281 .Huls, G.A., Heijnen, I.A., Cuomo, M.E., Koningsberger, J.C., Wiegman, L., Boel, E., van der Vuurst de Vries, A.R...
A fully monoclonal antibody (CS-D7, IgG1) specific for the iron regulated surface determinant B (IsdB) of was isolated from the Cambridge Antibody Technology () scFv antibody library. As compared to previously described IsdB specific monoclonals, CS-D7 has a unique, non-overlapping site on ...
My oncologist recommended adjuvant immunotherapy to prevent any recurrence. Immunotherapy is a relatively new treatment for cancer over the past decade or so. Nivolumab is a monoclonal antibody (-mab) that “switches on” the body’s own immune system in a way that over-rides the immune-blocking...
Several anticancer therapies targeting VEGFR with small molecules and antibody have been currently studied in preclinical and clinical studies. This article provides a review of human monoclonal antibody tanibirumab (TTAC-0001), which specifically binds VEGFR-2 and is currently being developed in ...
Panitumumab is the first fully human monoclonal antibody that binds to EGFr. Clinical activity has been demonstrated, most notably in patients with EGFr-positive metastatic colorectal cancer who have failed prior therapy. Phase III study results indicate a 46% reduction in the rate of tumor ...
AlliancesAsiaEurope MORE ON THIS TOPIC Layoffs Viracta Therapeutics Cuts 42% of Staff as Part of Resource Reprioritization November 7, 2024 · 2 min read · Angela Gabriel Earnings Moderna Gets Better-Than-Expected Q3 COVID-19 Vaccine Sales, but RSV Shot Disappoints...
“Over 30 companies and academic institutions globally have licensed our transgenic mouse platforms for their fully human monoclonal antibody discovery, with several programs at IND-ready stage, and one entered into clinical trial,” said Dr. Jingsong Wang, CEO of Harbour BioMed. “The increasing ad...